Yohannes; Daniel

Patent Applications and Registrations

Patent applications and USPTO patent grants for Yohannes; Daniel.The latest application filed is for "interconnections between quantum computing module and non-quantum processing modules in quantum computing systems".

Company Profile

9.27.40

Yohannes; Daniel - Elmsford NY
Yohannes; Daniel - Stamford CT
Yohannes; Daniel - Winston-Salem NC
Yohannes; Daniel - Cambridge MA
Yohannes; Daniel - New London CT
Yohannes; Daniel - Groton CT

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Interconnections Between Quantum Computing Module And Non-quantum Processing Modules In Quantum Computing Systems App 20220237495 - Yohannes; Daniel ; et al.	2022-07-28
Integrated superconducting nanowire digital photon detector Grant 11,385,099 - Jafari-Salim , et al. July 12, 2	2022-07-12
System And Method For Superconducting Multi-chip Module App 20210408355 - Yohannes; Daniel ; et al.	2021-12-30
System and method for superconducting multi-chip module Grant 11,121,302 - Yohannes , et al. September 14, 2	2021-09-14
Angiotensin (1-7) analogs and methods relating thereto Grant 10,829,519 - Gallagher , et al. November 10, 2	2020-11-10
System and method for providing multi-conductive layer metallic interconnects for superconducting integrated circuits Grant 10,833,243 - Tolpygo , et al. November 10, 2	2020-11-10
Combinations For The Treatment Of Kidney Stones App 20200261419 - Lowther; W. Todd ; et al.	2020-08-20
Glycolate Oxidase Inhibitors And Methods Of Use For The Treatment Of Kidney Stones App 20200262794 - Lowther; W. Todd ; et al.	2020-08-20
Nicotinic receptor non-competitive antagonists Grant 10,716,770 - Akireddy , et al.	2020-07-21
System And Method For Superconducting Multi-chip Module App 20200119251 - Yohannes; Daniel ; et al.	2020-04-16
HYPDH inhibitors and methods of use for the treatment of kidney stones Grant 10,562,844 - Lowther , et al. Feb	2020-02-18
HYPDH Inhibitors and Methods of Use for the Treatment of Kidney Stones App 20190382336 - Lowther; W. Todd ; et al.	2019-12-19
Nicotinic Receptor Non-Competitive Antagonists App 20190254991 - Akireddy; Srinivasa Rao ; et al.	2019-08-22
Angiotensin (1-7) Analogs And Methods Relating Thereto App 20190241616 - GALLAGHER; PATRICIA ; et al.	2019-08-08
Method for increasing the integration level of superconducting electronics circuits, and a resulting circuit Grant 10,283,694 - Yohannes , et al.	2019-05-07
Nicotinic receptor non-competitive antagonists Grant 10,258,582 - Akireddy , et al.	2019-04-16
Nicotinic Receptor Non-competitive Antagonists App 20180271806 - Akireddy; Srinivasa Rao ; et al.	2018-09-27
Hypdh Inhibitors And Methods Of Use For The Treatment Of Kidney Stones App 20180002275 - Lowther; W. Todd ; et al.	2018-01-04
Method For Increasing The Integration Level Of Superconducting Electronics Circuits, And A Resulting Circuit App 20170345990 - Yohannes; Daniel ; et al.	2017-11-30
Method for increasing the integration level of superconducting electronics circuits, and a resulting circuit Grant 9,741,918 - Yohannes , et al. August 22, 2	2017-08-22
System and method for providing multi-conductive layer metallic interconnects for superconducting integrated circuits Grant 9,741,920 - Tolpygo , et al. August 22, 2	2017-08-22
Preparation And Therapeutic Applications Of (2s,3r)-n-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluo- Robenzamide App 20170119746 - Bencherif; Merouane ; et al.	2017-05-04
Nicotinic Receptor Non-competitive Antagonists App 20170071878 - Akireddy; Srinivasa Rao ; et al.	2017-03-16
Nicotinic receptor non-competitive antagonists Grant 9,532,974 - Akireddy , et al. January 3, 2	2017-01-03
Nicotinic Receptor Non-competitive Antagonists App 20160008323 - Akireddy; Srinivasa Rao ; et al.	2016-01-14
Preparation and therapeutic applications of (2S,3R)-N-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluo- robenzamide Grant 9,173,876 - Bencherif , et al. November 3, 2	2015-11-03
System and method for providing multi-conductive layer metallic interconnects for superconducting integrated circuits Grant 9,130,116 - Tolpygo , et al. September 8, 2	2015-09-08
Method For Increasing The Integration Level Of Superconducting Electronics Circuits, And A Resulting Circuit App 20150119253 - Yohannes; Daniel ; et al.	2015-04-30
Preparation And Therapeutic Applications Of (2s,3r)-n-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluo- Robenzamide App 20150105421 - Bencherif; Merouane ; et al.	2015-04-16
Diazabicyclo[3.3.1]nonanes, Methods Of Synthesis, And Uses Thereof App 20150031675 - Strachan; Jon-Paul ; et al.	2015-01-29
Preparation and therapeutic applications of (2S, 3R)-N-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]OCT-3-yl)-3,5-difluorobe- nzamide Grant 8,901,151 - Bencherif , et al. December 2, 2	2014-12-02
Nicotinic Receptor Non-competitive Antagonists App 20140315877 - Akireddy; Srinivasa Rao ; et al.	2014-10-23
Nicotinic Receptor Non-competitive Antagonists App 20140288169 - Akireddy; Srinivasa Rao ; et al.	2014-09-25
Nicotinic Receptor Non-competitive Modulators App 20140288185 - Akireddy; Srinivasa Rao ; et al.	2014-09-25
Nicotinic receptor non-competitive antagonists Grant 8,809,397 - Akireddy , et al. August 19, 2	2014-08-19
Preparation And Therapeutic Applications Of (2s, 3r)-n-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluorobe- Nzamide App 20140163065 - Bencherif; Merouane ; et al.	2014-06-12
Synthesis And Novel Salt Forms Of (r)-3-((e)-2-(pyrrolidin-3-yl)vinyl)-5-(tetrahydropyran-4-yloxy)pyridine App 20140107163 - Akireddy; Srinvasa Rao ; et al.	2014-04-17
Synthesis and novel salt forms of (R)-3-((E)-pyrrolidin-3-yl)vinyl)-5-tetrahydropyran-4-yloxy)pyridine Grant 8,633,227 - Akireddy , et al. January 21, 2	2014-01-21
Nicotinic Receptor Non-competitive Antagonists App 20130203860 - Akireddy; Srinivasa Rao ; et al.	2013-08-08
Preparation and therapeutic applications of (2S,3R)-N-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]OCT-3-yl)-3,5-difluo- robenzamide Grant 8,476,296 - Bencherif , et al. July 2, 2	2013-07-02
System and method for providing multi-conductive layer metallic interconnects for superconducting integrated circuits Grant 8,437,818 - Tolpygo , et al. May 7, 2	2013-05-07
System and method for providing multi-conductive layer metallic interconnects for superconducting integrated circuits Grant 8,301,214 - Tolpygo , et al. October 30, 2	2012-10-30
Fused Benzoazepines As Neuronal Nicotinic Acetylcholine Receptor Ligands App 20120053168 - Bhatti; Balwinder Singh ; et al.	2012-03-01
Synthesis and Novel Salt Forms of (R)-3-((E)-pyrrolidin-3-yl)vinyl)-5-tetrahydropyran-4-yloxy)pyridine App 20120015983 - Akireddy; Srinivasa Rao ; et al.	2012-01-19
Amides Of Diazabicyclooctanes And Uses Thereof App 20110263629 - Strachan; Jon-Paul ; et al.	2011-10-27
Preparation And Therapeutic Applications Of (2s,3r)-n-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluo- Robenzamide App 20110257224 - Bencherif; Merouane ; et al.	2011-10-20
Derivatives Of Oxabispidine As Neuronal Nicotinic Acetylcholine Receptor Ligands App 20110257168 - Akireddy; Srinivasa R. ; et al.	2011-10-20
Aryl and heteroaryltetrahydrocyclobutapyrroles as nicotinic acetylcholine receptor ligands Grant 7,816,356 - Yohannes October 19, 2	2010-10-19
1, 2, 3, 3a, 8, 8a-hexahydro-2, 7a-diada-cyclopenta[a]inden-7-one Derivatives Which Bind To Neuronal Nicotinic Acetylcholine Specific Receptor Sites And Are Useful In Modulating Cholinergic Function And In The Treatment Of Addictive Disorders App 20090093512 - O'Neill; Brian T. ; et al.	2009-04-09
Heterocyclic compounds as ligands of the GABAA receptor Grant 6,949,562 - Yohannes , et al. September 27, 2	2005-09-27
Aryl and heteroaryltetrahydrocyclobutapyrroles as nicotinic acetylcholine receptor ligands App 20050182063 - Yohannes, Daniel	2005-08-18
Muscarinic receptor agonists Grant 6,911,477 - Villalobos , et al. June 28, 2	2005-06-28
Cycloalkypyrrole-3-carboxylic acid derivatives and heterocycloalkylpyrrole-3-carboxylic acid derivatives Grant 6,861,529 - Yohannes , et al. March 1, 2	2005-03-01
Heterocyclic compounds as ligands of the GABAA receptor App 20040110778 - Yohannes, Daniel ; et al.	2004-06-10
7-hetero-bicyclo[2.2.1]-heptanes App 20030236405 - Yohannes, Daniel ; et al.	2003-12-25
Heterocyclic compounds as ligands of the GABAA receptor Grant 6,653,471 - Yohannes , et al. November 25, 2	2003-11-25
Novel muscarinic receptor agonists App 20030171349 - Villalobos, Anabella ; et al.	2003-09-11
Heterocyclic compounds as ligands of the GABAA receptor App 20030105081 - Yohannes, Daniel ; et al.	2003-06-05
Cycloalkylpyrrole-3-carboxylic acid derivatives and heterocycloalkylpyrrole-3-carboxylic acid derivatives App 20030069416 - Yohannes, Daniel ; et al.	2003-04-10
Novel muscarinic receptor agonists App 20020103194 - Villalobos, Anabella ; et al.	2002-08-01
7-Hetero-bicyclo[2.2.1]-heptanes App 20020038028 - Yohannes, Daniel ; et al.	2002-03-28
7-hetero-bicyclo[2.2.1]-heptanes App 20020035262 - Yohannes, Daniel ; et al.	2002-03-21

Company Registrations

SEC

0001699621

Yohannes Daniel

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.